How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015–2021 Article Swipe
Julian Perelman
,
Filipa Duarte‐Ramos
,
A Melo Gouveia
,
Luís Pinheiro
,
Francisco Ramos
,
Sabine Vogler
,
Céu Mateus
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1080/14737167.2023.2146579
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1080/14737167.2023.2146579
The findings suggest a need for capacity-building on biosimilar prescribing, including for doctors of academic hospitals and those working in settings where high biosimilar use would be expected.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1080/14737167.2023.2146579
- OA Status
- green
- Cited By
- 6
- References
- 33
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4308768693
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4308768693Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1080/14737167.2023.2146579Digital Object Identifier
- Title
-
How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015–2021Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-11-10Full publication date if available
- Authors
-
Julian Perelman, Filipa Duarte‐Ramos, A Melo Gouveia, Luís Pinheiro, Francisco Ramos, Sabine Vogler, Céu MateusList of authors in order
- Landing page
-
https://doi.org/10.1080/14737167.2023.2146579Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://hdl.handle.net/10216/151478Direct OA link when available
- Concepts
-
Biosimilar, Medicine, Infliximab, Euros, Consumption (sociology), Portuguese, Family medicine, Internal medicine, Disease, Linguistics, Humanities, Social science, Sociology, PhilosophyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
6Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 3, 2023: 1Per-year citation counts (last 5 years)
- References (count)
-
33Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4308768693 |
|---|---|
| doi | https://doi.org/10.1080/14737167.2023.2146579 |
| ids.doi | https://doi.org/10.1080/14737167.2023.2146579 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/36356294 |
| ids.openalex | https://openalex.org/W4308768693 |
| fwci | 0.70856031 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000068879 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Adalimumab |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D059451 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Biosimilar Pharmaceuticals |
| mesh[3].qualifier_ui | Q000627 |
| mesh[3].descriptor_ui | D000069285 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | therapeutic use |
| mesh[3].descriptor_name | Infliximab |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D011174 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Portugal |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D000069283 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Rituximab |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D013222 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | State Medicine |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D008137 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Longitudinal Studies |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D006801 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Humans |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000068879 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Adalimumab |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D059451 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Biosimilar Pharmaceuticals |
| mesh[11].qualifier_ui | Q000627 |
| mesh[11].descriptor_ui | D000069285 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | therapeutic use |
| mesh[11].descriptor_name | Infliximab |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D011174 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Portugal |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D000069283 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Rituximab |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D013222 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | State Medicine |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D008137 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Longitudinal Studies |
| type | article |
| title | How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015–2021 |
| biblio.issue | 1 |
| biblio.volume | 23 |
| biblio.last_page | 109 |
| biblio.first_page | 99 |
| topics[0].id | https://openalex.org/T12255 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Biosimilars and Bioanalytical Methods |
| topics[1].id | https://openalex.org/T11792 |
| topics[1].field.id | https://openalex.org/fields/20 |
| topics[1].field.display_name | Economics, Econometrics and Finance |
| topics[1].score | 0.9987999796867371 |
| topics[1].domain.id | https://openalex.org/domains/2 |
| topics[1].domain.display_name | Social Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2002 |
| topics[1].subfield.display_name | Economics and Econometrics |
| topics[1].display_name | Pharmaceutical Economics and Policy |
| topics[2].id | https://openalex.org/T10804 |
| topics[2].field.id | https://openalex.org/fields/20 |
| topics[2].field.display_name | Economics, Econometrics and Finance |
| topics[2].score | 0.9966999888420105 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2002 |
| topics[2].subfield.display_name | Economics and Econometrics |
| topics[2].display_name | Health Systems, Economic Evaluations, Quality of Life |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C59491497 |
| concepts[0].level | 2 |
| concepts[0].score | 0.9897089004516602 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q864715 |
| concepts[0].display_name | Biosimilar |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.7484740018844604 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2777138892 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6459519863128662 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q415264 |
| concepts[2].display_name | Infliximab |
| concepts[3].id | https://openalex.org/C2778097690 |
| concepts[3].level | 2 |
| concepts[3].score | 0.4531427323818207 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q5413797 |
| concepts[3].display_name | Euros |
| concepts[4].id | https://openalex.org/C30772137 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4345672130584717 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q5164762 |
| concepts[4].display_name | Consumption (sociology) |
| concepts[5].id | https://openalex.org/C35219183 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4287257194519043 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q5146 |
| concepts[5].display_name | Portuguese |
| concepts[6].id | https://openalex.org/C512399662 |
| concepts[6].level | 1 |
| concepts[6].score | 0.34416937828063965 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[6].display_name | Family medicine |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.31787770986557007 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| concepts[8].id | https://openalex.org/C2779134260 |
| concepts[8].level | 2 |
| concepts[8].score | 0.0 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[8].display_name | Disease |
| concepts[9].id | https://openalex.org/C41895202 |
| concepts[9].level | 1 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q8162 |
| concepts[9].display_name | Linguistics |
| concepts[10].id | https://openalex.org/C15708023 |
| concepts[10].level | 1 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q80083 |
| concepts[10].display_name | Humanities |
| concepts[11].id | https://openalex.org/C36289849 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q34749 |
| concepts[11].display_name | Social science |
| concepts[12].id | https://openalex.org/C144024400 |
| concepts[12].level | 0 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q21201 |
| concepts[12].display_name | Sociology |
| concepts[13].id | https://openalex.org/C138885662 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q5891 |
| concepts[13].display_name | Philosophy |
| keywords[0].id | https://openalex.org/keywords/biosimilar |
| keywords[0].score | 0.9897089004516602 |
| keywords[0].display_name | Biosimilar |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.7484740018844604 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/infliximab |
| keywords[2].score | 0.6459519863128662 |
| keywords[2].display_name | Infliximab |
| keywords[3].id | https://openalex.org/keywords/euros |
| keywords[3].score | 0.4531427323818207 |
| keywords[3].display_name | Euros |
| keywords[4].id | https://openalex.org/keywords/consumption |
| keywords[4].score | 0.4345672130584717 |
| keywords[4].display_name | Consumption (sociology) |
| keywords[5].id | https://openalex.org/keywords/portuguese |
| keywords[5].score | 0.4287257194519043 |
| keywords[5].display_name | Portuguese |
| keywords[6].id | https://openalex.org/keywords/family-medicine |
| keywords[6].score | 0.34416937828063965 |
| keywords[6].display_name | Family medicine |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.31787770986557007 |
| keywords[7].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1080/14737167.2023.2146579 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S98544388 |
| locations[0].source.issn | 1473-7167, 1744-8379 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1473-7167 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Expert Review of Pharmacoeconomics & Outcomes Research |
| locations[0].source.host_organization | https://openalex.org/P4310320547 |
| locations[0].source.host_organization_name | Taylor & Francis |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320547 |
| locations[0].source.host_organization_lineage_names | Taylor & Francis |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Expert Review of Pharmacoeconomics & Outcomes Research |
| locations[0].landing_page_url | https://doi.org/10.1080/14737167.2023.2146579 |
| locations[1].id | pmid:36356294 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Expert review of pharmacoeconomics & outcomes research |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/36356294 |
| locations[2].id | pmh:oai:eprints.lancs.ac.uk:183850 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401916 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Lancaster EPrints (Lancaster University) |
| locations[2].source.host_organization | https://openalex.org/I67415387 |
| locations[2].source.host_organization_name | Lancaster University |
| locations[2].source.host_organization_lineage | https://openalex.org/I67415387 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | acceptedVersion |
| locations[2].raw_type | PeerReviewed |
| locations[2].license_id | |
| locations[2].is_accepted | True |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | |
| locations[3].id | pmh:oai:repositorio-aberto.up.pt:10216/151478 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306401934 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Open Repository of the University of Porto (University of Porto) |
| locations[3].source.host_organization | https://openalex.org/I182534213 |
| locations[3].source.host_organization_name | Universidade do Porto |
| locations[3].source.host_organization_lineage | https://openalex.org/I182534213 |
| locations[3].license | cc-by-nc-nd |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | |
| locations[3].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://hdl.handle.net/10216/151478 |
| locations[4].id | pmh:oai:run.unl.pt:10362/151551 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S4306400678 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | Universidade Nova de Lisboa's Repository (Universidade Nova de Lisboa) |
| locations[4].source.host_organization | https://openalex.org/I83558840 |
| locations[4].source.host_organization_name | Universidade Nova de Lisboa |
| locations[4].source.host_organization_lineage | https://openalex.org/I83558840 |
| locations[4].license | other-oa |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | |
| locations[4].license_id | https://openalex.org/licenses/other-oa |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | |
| locations[4].landing_page_url | http://hdl.handle.net/10362/151551 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5004622473 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6634-9000 |
| authorships[0].author.display_name | Julian Perelman |
| authorships[0].countries | PT |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I141596103 |
| authorships[0].affiliations[0].raw_affiliation_string | NOVA National School of Public Health, Comprehensive Health Research Center, CHRC, NOVA University of Lisbon, Lisbon, Portugal |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I141596103 |
| authorships[0].affiliations[1].raw_affiliation_string | Comprehensive Health Research Center, Nova University of Lisbon, Portugal |
| authorships[0].institutions[0].id | https://openalex.org/I141596103 |
| authorships[0].institutions[0].ror | https://ror.org/01c27hj86 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I141596103 |
| authorships[0].institutions[0].country_code | PT |
| authorships[0].institutions[0].display_name | University of Lisbon |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Julian Perelman |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Comprehensive Health Research Center, Nova University of Lisbon, Portugal, NOVA National School of Public Health, Comprehensive Health Research Center, CHRC, NOVA University of Lisbon, Lisbon, Portugal |
| authorships[1].author.id | https://openalex.org/A5018306869 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6632-2553 |
| authorships[1].author.display_name | Filipa Duarte‐Ramos |
| authorships[1].countries | PT |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I141596103 |
| authorships[1].affiliations[0].raw_affiliation_string | Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Portugal |
| authorships[1].institutions[0].id | https://openalex.org/I141596103 |
| authorships[1].institutions[0].ror | https://ror.org/01c27hj86 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I141596103 |
| authorships[1].institutions[0].country_code | PT |
| authorships[1].institutions[0].display_name | University of Lisbon |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Filipa Duarte-Ramos |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Portugal |
| authorships[2].author.id | https://openalex.org/A5103628315 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | A Melo Gouveia |
| authorships[2].countries | PT |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210111164 |
| authorships[2].affiliations[0].raw_affiliation_string | Instituto Português de Oncologia de Lisboa, Portugal |
| authorships[2].institutions[0].id | https://openalex.org/I4210111164 |
| authorships[2].institutions[0].ror | https://ror.org/027ras364 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210111164 |
| authorships[2].institutions[0].country_code | PT |
| authorships[2].institutions[0].display_name | IPO Porto |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | António Melo Gouveia |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Instituto Português de Oncologia de Lisboa, Portugal |
| authorships[3].author.id | https://openalex.org/A5108473355 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Luís Pinheiro |
| authorships[3].countries | PT |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210114390 |
| authorships[3].affiliations[0].raw_affiliation_string | Centro Hospitalar Universitário de Lisboa Norte, Portugal |
| authorships[3].institutions[0].id | https://openalex.org/I4210114390 |
| authorships[3].institutions[0].ror | https://ror.org/020sr6z07 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210114390 |
| authorships[3].institutions[0].country_code | PT |
| authorships[3].institutions[0].display_name | Centro Hospitalar Lisboa Norte |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Luis Pinheiro |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Centro Hospitalar Universitário de Lisboa Norte, Portugal |
| authorships[4].author.id | https://openalex.org/A5031334931 |
| authorships[4].author.orcid | https://orcid.org/0009-0007-5741-0958 |
| authorships[4].author.display_name | Francisco Ramos |
| authorships[4].countries | PT |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I141596103 |
| authorships[4].affiliations[0].raw_affiliation_string | NOVA National School of Public Health, Comprehensive Health Research Center, CHRC, NOVA University of Lisbon, Lisbon, Portugal |
| authorships[4].institutions[0].id | https://openalex.org/I141596103 |
| authorships[4].institutions[0].ror | https://ror.org/01c27hj86 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I141596103 |
| authorships[4].institutions[0].country_code | PT |
| authorships[4].institutions[0].display_name | University of Lisbon |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Francisco Ramos |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | NOVA National School of Public Health, Comprehensive Health Research Center, CHRC, NOVA University of Lisbon, Lisbon, Portugal |
| authorships[5].author.id | https://openalex.org/A5035589649 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-4853-4397 |
| authorships[5].author.display_name | Sabine Vogler |
| authorships[5].countries | AT |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210122114 |
| authorships[5].affiliations[0].raw_affiliation_string | WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Austrian National Public Health Institute (Gesundheit Österreich GmbH/GÖG), Austria |
| authorships[5].institutions[0].id | https://openalex.org/I4210122114 |
| authorships[5].institutions[0].ror | https://ror.org/02m68mv75 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210122114 |
| authorships[5].institutions[0].country_code | AT |
| authorships[5].institutions[0].display_name | Gesundheit Österreich |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Sabine Vogler |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Austrian National Public Health Institute (Gesundheit Österreich GmbH/GÖG), Austria |
| authorships[6].author.id | https://openalex.org/A5043712835 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-6219-219X |
| authorships[6].author.display_name | Céu Mateus |
| authorships[6].countries | GB |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I67415387 |
| authorships[6].affiliations[0].raw_affiliation_string | Health Economics at Lancaster, Division of Health Research, Lancaster University, Lancaster, UK |
| authorships[6].institutions[0].id | https://openalex.org/I67415387 |
| authorships[6].institutions[0].ror | https://ror.org/04f2nsd36 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I67415387 |
| authorships[6].institutions[0].country_code | GB |
| authorships[6].institutions[0].display_name | Lancaster University |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Céu Mateus |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Health Economics at Lancaster, Division of Health Research, Lancaster University, Lancaster, UK |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://hdl.handle.net/10216/151478 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015–2021 |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12255 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Biosimilars and Bioanalytical Methods |
| related_works | https://openalex.org/W2914532353, https://openalex.org/W4385064586, https://openalex.org/W4229777120, https://openalex.org/W1981336058, https://openalex.org/W2077942718, https://openalex.org/W2774189845, https://openalex.org/W2587157414, https://openalex.org/W2924476097, https://openalex.org/W3010465489, https://openalex.org/W1575821808 |
| cited_by_count | 6 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 3 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 1 |
| locations_count | 5 |
| best_oa_location.id | pmh:oai:repositorio-aberto.up.pt:10216/151478 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306401934 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Open Repository of the University of Porto (University of Porto) |
| best_oa_location.source.host_organization | https://openalex.org/I182534213 |
| best_oa_location.source.host_organization_name | Universidade do Porto |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I182534213 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://hdl.handle.net/10216/151478 |
| primary_location.id | doi:10.1080/14737167.2023.2146579 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S98544388 |
| primary_location.source.issn | 1473-7167, 1744-8379 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1473-7167 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Expert Review of Pharmacoeconomics & Outcomes Research |
| primary_location.source.host_organization | https://openalex.org/P4310320547 |
| primary_location.source.host_organization_name | Taylor & Francis |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320547 |
| primary_location.source.host_organization_lineage_names | Taylor & Francis |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Expert Review of Pharmacoeconomics & Outcomes Research |
| primary_location.landing_page_url | https://doi.org/10.1080/14737167.2023.2146579 |
| publication_date | 2022-11-10 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W2513403311, https://openalex.org/W2600333833, https://openalex.org/W4281869089, https://openalex.org/W3028506075, https://openalex.org/W2337110222, https://openalex.org/W2802491527, https://openalex.org/W3021316203, https://openalex.org/W3115637958, https://openalex.org/W2617581275, https://openalex.org/W3134201905, https://openalex.org/W2951219144, https://openalex.org/W2793866077, https://openalex.org/W3178524654, https://openalex.org/W3134678138, https://openalex.org/W3087454785, https://openalex.org/W3020440359, https://openalex.org/W3093995684, https://openalex.org/W2549300825, https://openalex.org/W3022365662, https://openalex.org/W2611064734, https://openalex.org/W2910990828, https://openalex.org/W2897025489, https://openalex.org/W4220852316, https://openalex.org/W2778747082, https://openalex.org/W3177193828, https://openalex.org/W3000333445, https://openalex.org/W3013248954, https://openalex.org/W3097476217, https://openalex.org/W3106651340, https://openalex.org/W3110799421, https://openalex.org/W2926307819, https://openalex.org/W2930500067, https://openalex.org/W2754502404 |
| referenced_works_count | 33 |
| abstract_inverted_index.a | 3 |
| abstract_inverted_index.be | 26 |
| abstract_inverted_index.in | 19 |
| abstract_inverted_index.of | 13 |
| abstract_inverted_index.on | 7 |
| abstract_inverted_index.The | 0 |
| abstract_inverted_index.and | 16 |
| abstract_inverted_index.for | 5, 11 |
| abstract_inverted_index.use | 24 |
| abstract_inverted_index.high | 22 |
| abstract_inverted_index.need | 4 |
| abstract_inverted_index.those | 17 |
| abstract_inverted_index.where | 21 |
| abstract_inverted_index.would | 25 |
| abstract_inverted_index.doctors | 12 |
| abstract_inverted_index.suggest | 2 |
| abstract_inverted_index.working | 18 |
| abstract_inverted_index.academic | 14 |
| abstract_inverted_index.findings | 1 |
| abstract_inverted_index.settings | 20 |
| abstract_inverted_index.expected. | 27 |
| abstract_inverted_index.hospitals | 15 |
| abstract_inverted_index.including | 10 |
| abstract_inverted_index.biosimilar | 8, 23 |
| abstract_inverted_index.prescribing, | 9 |
| abstract_inverted_index.capacity-building | 6 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5004622473 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 7 |
| corresponding_institution_ids | https://openalex.org/I141596103 |
| citation_normalized_percentile.value | 0.6364328 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |